Public Comment for AAN Guideline DRAFT Manuscript: "Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Update: Report of the AAN Guidelines Subcommittee"
The public comment period for the AAN Pharmacologic Migraine Prevention Guideline concluded on 9/8/2024.
Please contact guidelines@aan.com with any questions.
Please contact guidelines@aan.com with any questions.
This content is neither created nor endorsed by Google. - Terms of Service - Privacy Policy
Does this form look suspicious? Report
